Pilgrim's Pride Corporation
30.24USD
+0.2500 (+0.83%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.72▼ | $1.11 | 0 | 3 |
| Next quarter | $0.51▼ | $0.67 | 1 | 2 |
| Current year | $2.49▼ | $3.48 | 0 | 5 |
| Next year | $2.89▼ | $3.78 | 0 | 5 |
Beat in 1 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.66 | $0.64 | -0.02 (-3.4%) |
| 2026-03-31 | $0.65 | $0.51 | -0.14 (-21.2%) |
| 2025-12-31 | $0.76 | $0.68 | -0.07 (-9.9%) |
| 2025-09-30 | $1.38 | $1.52 | +0.14 (+9.9%) |
86 ratings from 18 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| UBS | Maintained | Neutral | $30 $28 | Aug 7, 2026 |
| B of A Securities | Maintained | Neutral | $37 $30 | Jul 2, 2026 |
| UBS | Initiated | Neutral | $30 | May 19, 2026 |
| Barclays | Upgraded from Equal-Weight | Overweight | $45 $42 | May 1, 2026 |
| Goldman Sachs | Maintained | Neutral | $44 $39 | Apr 9, 2026 |
| BMO Capital | Maintained | Market Perform | $42 $40 | Mar 25, 2026 |
| BMO Capital | Maintained | Market Perform | $40 $42 | Feb 13, 2026 |
| Barclays | Maintained | Equal-Weight | $49 $45 | Dec 9, 2025 |
| Goldman Sachs | Maintained | Neutral | $54 $46 | Oct 13, 2025 |
| Goldman Sachs | Initiated | Neutral | $50 | Jun 23, 2025 |
| BMO Capital | Maintained | Market Perform | $47 $48 | Mar 17, 2025 |
| Barclays | Maintained | Equal-Weight | $45 $49 | Nov 1, 2024 |
| BMO Capital | Maintained | Market Perform | $42 $43 | Nov 1, 2024 |
| Barclays | Maintained | Equal-Weight | $43 $45 | Sep 9, 2024 |
| Argus Research | Maintained | Buy | $50 $55 | Aug 28, 2024 |
| B of A Securities | Downgraded from Buy | Neutral | $47 | Aug 15, 2024 |
| BMO Capital | Downgraded from Outperform | Market Perform | $46 | Aug 12, 2024 |
| BMO Capital | Maintained | Outperform | $43 $46 | Aug 2, 2024 |
| Barclays | Maintained | Equal-Weight | $40 $43 | Aug 2, 2024 |
| Barclays | Maintained | Equal-Weight | $38 $40 | Jul 25, 2024 |
| Argus Research | Maintained | Buy | $41 $50 | Jul 23, 2024 |
| B of A Securities | Maintained | Buy | $40 $42 | Jul 10, 2024 |
| Argus Research | Initiated | Buy | $41 | Jun 18, 2024 |
| Goldman Sachs | Maintained | Neutral | $32 $36 | Apr 17, 2024 |
| Barclays | Downgraded from Overweight | Equal-Weight | $35 $38 | Apr 16, 2024 |
30 filings from 12 insiders · 0 buy / 0 sell over 6m
Officers and directors of PPC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| MAESTRI KAROLESKI JOANITA MARIADirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| ANDRE NOGUEIRA DE SOUZADirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| TOMAZONI GILBERTODirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| BATISTA JOESLEY MENDONCADirector and Beneficial Owner of more than 10% of a Class of Security | Grant | 1.9k | — | — | Apr 29, 2026 |
| BATISTA WESLEY MENDONCADirector and Beneficial Owner of more than 10% of a Class of Security | Grant | 1.9k | — | — | Apr 29, 2026 |
| PADILLA RAULDirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| VASCONCELLOS WALLIM CRUZ DE JRDirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| ASLAM FARHADirector | Grant | 1.9k | — | — | Apr 29, 2026 |
| CELIS ARQUIMEDES A.Director | Grant | 1.9k | — | — | Apr 29, 2026 |
| GALVANONI MATTHEW R.Chief Financial Officer | Sell | 7.0k | $43.52 | $303k | Feb 18, 2026 |
| GALVANONI MATTHEW R.Chief Financial Officer | Other | 3.6k | — | — | Feb 17, 2026 |
| SANDRI FABIOChief Executive Officer | Other | 6.7k | — | — | Feb 17, 2026 |
| GALVANONI MATTHEW R.Chief Financial Officer | Grant | 15.7k | — | — | Feb 11, 2026 |
| SANDRI FABIOChief Executive Officer | Grant | 30.2k | — | — | Feb 11, 2026 |
| SANDRI FABIOChief Executive Officer | Sell | 70.0k | $45.83 | $3.21M | Jun 9, 2025 |
| MAESTRI KAROLESKI JOANITA MARIADirector | Grant | 1.1k | — | — | Apr 30, 2025 |
| CELIS ARQUIMEDES A.Director | Grant | 1.1k | — | — | Apr 30, 2025 |
| ASLAM FARHADirector | Grant | 1.1k | — | — | Apr 30, 2025 |
| VASCONCELLOS WALLIM CRUZ DE JRDirector | Grant | 1.1k | — | — | Apr 30, 2025 |
| ANDRE NOGUEIRA DE SOUZADirector | Grant | 1.1k | — | — | Apr 30, 2025 |
No analyst notes on PPC yet.
Analyst Ratings
7 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 1 | 6 | 0 | 0 | Hold2.63 |
| 1 mo ago | 1 | 1 | 7 | 0 | 0 | Hold2.67 |
| 2 mo ago | 1 | 2 | 6 | 0 | 0 | Hold2.56 |